Categories: India

Shimla Pharmacies Implement Revised GST on Medicines by up to 10 per cent, Bringing Major Relief to Patients

Pharmacies in Shimla have started applying the revised GST night tariff on medicines, effective September 22, reducing prices of essential and life-saving drugs. Items previously taxed at 12% or 18% now attract 5% or are tax-exempt, including insulin and cancer medicines, giving patients savings up to 10%. Retailers and managers confirm smoother implementation, while consumers report immediate benefits. Experts predict increased affordability, higher consumption, and improved GST compliance in the pharmaceutical sector.

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by NewsX Syndication
Last updated: September 26, 2025 17:37:30 IST

Shimla (Himachal Pradesh) [India], September 26 (ANI): The Pharmaceutical companies and chemists in Shimla have begun implementing the revised GST night tariff on medicines, bringing much-needed relief to patients and the poor. Managers and pharmacy owners in the capital confirmed that the new reforms, effective as of September 22, have already reduced the prices of many essential and life-saving medications.

Mahesh Bisht, Manager at a pharmaceutical company, explained the changes, “From September 22, the new GST reforms and tariffs have come into effect. Items that were earlier under the 12% GST slab have now been reduced by 6.25% from the Maximum Retail Price (MRP). Similarly, in the 18% category, medicines are seeing a reduction of around 11.2%. Some items remain unchanged at 18%, but overall, patients are getting a benefit of about 6.2%.”

He added, “For example, if an item costs ₹100, consumers are saving ₹6.20 directly. We started executing this from the morning of September 22, and so far there have been no difficulties,” Bisht told ANI.

Chemists in the Lower Bazar area have also welcomed the move. Mukul Sood, a pharmacy shop owner, said. “We have implemented this across all retailers and dealers. On average, consumers will save about 10%. This is a commendable decision by the government, especially during the festive season. It will not only bring relief to people but also increase GST compliance.”

Sood added, “With lower rates, consumption is expected to rise, and government collections will eventually increase. Earlier, medicines were taxed in four slabs 12%, 18%, 5%, and 0%. Now, the 12% slab has been scrapped completely; most medicines are taxed at 5%, while insulin and many life-saving drugs are exempt from tax. Expensive drugs like cancer medicines have also become tax-free. Patients will see major benefits.”

Patients themselves confirmed the impact. Vijay, a consumer purchasing medicines, shared his experience, “Because of the new GST implementation, I am getting medicines at much cheaper rates. For example, a medicine that used to cost me ₹400 is now available at ₹356. This is a huge relief. The reforms have already started benefiting patients, and we are hopeful this will continue,” Vijay said.

Ashish Chandel, another representative from a pharmaceutical company in Lower Bazar, said his firm had also begun implementing the government’s directives from September 22.

“Most medicines that were taxed at 12% or 18% are now under the 5% slab, except a few cosmetics. For old stock, we are selling at a discount of 6.25% from the MRP. While we are awaiting clarity on the government’s input credit, we have already started executing the orders at the all-India level. Consumers are getting significant relief, especially on branded medicines that were earlier very costly. Prices have effectively dropped from 18% to 5%, and customers are noticing the difference immediately,” Chandel said.

The changes are expected to substantially reduce the burden on patients in Himachal Pradesh, particularly those requiring costly and long-term medication. Experts say this reform could transform affordability and also improve compliance in the pharmaceutical sector. (ANI)

Source The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.

Recent Posts

Big Twist Before the Big Screen: SS Rajamouli’s ‘Varanasi’ Release Date Pushed, Mahesh Babu–Priyanka Chopra Epic Awaits New Date

Big Twist Before the Big Screen: SS Rajamouli’s ‘Varanasi’ Release Date Pushed, Mahesh Babu–Priyanka Chopra Epic Awaits New Date

SS Rajamouli’s Varanasi, starring Mahesh Babu and Priyanka Chopra, now releases April 7, 2027. The…

January 30, 2026

Airtel Partners With Adobe: Get A Free One-Year Subscription Worth Rs.4,000 To Design Graphics And Edit Videos, Check How To Get Benefits

Airtel has partnered with Adobe to offer Adobe Express Premium free for one year to…

January 30, 2026

Swiggy Share Price After Q3FY26: Slump 7% Amid Rising Losses Despite Revenue Growth- Here’s A What Investors Should Know

Swiggy Q3FY26: Swiggy shares slip as Q3FY26 losses widen to ₹1,065 crore despite 54% revenue…

January 30, 2026